INVO BioScience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch INVO and buy or sell other stocks, ETFs, and their options commission-free!

About INVO

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. 

CEO
Steven M. Shum
CEOSteven M. Shum
Employees
Employees
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
Founded
Employees
Employees

INVO Key Statistics

Market cap
363.39K
Market cap363.39K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
30.59K
Average volume30.59K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$360.00
52 Week high$360.00
52 Week low
$1.85
52 Week low$1.85

Stock Snapshot

INVO BioScience(INVO) stock is priced at $2.68, giving the company a market capitalization of 363.39K.

On 2026-05-02, INVO BioScience(INVO) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 30.59K.

The stock's 52-week range extends from a low of $1.85 to a high of $360.00.

The stock's 52-week range extends from a low of $1.85 to a high of $360.00.

People also own

Based on the portfolios of people who own INVO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.